LIF vs. BSX
LIF (Life360, Inc.) and BSX (Boston Scientific Corporation) are both stocks. LIF operates in Software - Application (Technology), while BSX operates in Medical Devices (Healthcare). Over the past year, LIF returned -25.93% vs -52.97% for BSX. At a 0.25 correlation, their price movements are largely independent.
Performance
LIF vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, LIF achieves a -29.45% return, which is significantly higher than BSX's -50.80% return.
LIF
- 1D
- -0.07%
- 1M
- 17.44%
- YTD
- -29.45%
- 6M
- -33.03%
- 1Y
- -25.93%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BSX
- 1D
- -0.55%
- 1M
- -10.95%
- YTD
- -50.80%
- 6M
- -49.33%
- 1Y
- -52.97%
- 3Y*
- -2.85%
- 5Y*
- 1.80%
- 10Y*
- 7.42%
LIF vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
LIF Life360, Inc. | -29.45% | 55.42% | 58.73% |
BSX Boston Scientific Corporation | -50.80% | 6.75% | 17.70% |
Correlation
The correlation between LIF and BSX is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jun 6, 2024 | 0.25 |
The correlation between LIF and BSX shifts across timeframes, from 0.14 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
LIF:
$3.88B
BSX:
$70.13B
LIF:
$1.75
BSX:
$2.38
LIF:
25.86
BSX:
19.74
LIF:
7.30
BSX:
3.40
LIF:
6.49
BSX:
2.71
LIF:
$528.98M
BSX:
$20.62B
LIF:
$407.86M
BSX:
$14.52B
LIF:
$26.53M
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LIF vs. BSX — Risk / Return Rank
LIF
BSX
LIF vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Life360, Inc. (LIF) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LIF | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.09 | ||
| Sortino ratioReturn per unit of downside risk | +2.04 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.67 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | -0.43 | -0.93 | +0.49 |
| Martin ratioReturn relative to average drawdown | -0.70 | -2.00 | +1.30 |
Loading charts...
Drawdowns
LIF vs. BSX - Drawdown Comparison
The maximum LIF drawdown since its inception was -65.64%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for LIF and BSX.
Loading charts...
Drawdown Indicators
| LIF | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.64% | -89.15% | +23.51% |
Max Drawdown (1Y)Largest decline over 1 year | -65.64% | -56.62% | -9.02% |
Max Drawdown (3Y)Largest decline over 3 years | — | -56.62% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -56.62% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -56.62% | — |
Current DrawdownCurrent decline from peak | -59.19% | -56.62% | -2.57% |
Average DrawdownAverage peak-to-trough decline | -21.35% | -38.76% | +17.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 40.82% | 26.23% | +14.59% |
Volatility
LIF vs. BSX - Volatility Comparison
Life360, Inc. (LIF) has a higher volatility of 16.67% compared to Boston Scientific Corporation (BSX) at 15.84%. This indicates that LIF's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LIF | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.67% | 15.84% | +0.83% |
Volatility (6M)Calculated over the trailing 6-month period | 52.85% | 32.83% | +20.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 67.08% | 34.77% | +32.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 62.97% | 25.69% | +37.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 62.97% | 27.29% | +35.68% |
Dividends
LIF vs. BSX - Dividend Comparison
Neither LIF nor BSX has paid dividends to shareholders.
Financials
LIF vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Life360, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LIF vs. BSX - Profitability Comparison
LIF - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Life360, Inc. reported a gross profit of 110.56M and revenue of 143.12M. Therefore, the gross margin over that period was 77.3%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
LIF - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Life360, Inc. reported an operating income of -8.08M and revenue of 143.12M, resulting in an operating margin of -5.6%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
LIF - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Life360, Inc. reported a net income of 2.78M and revenue of 143.12M, resulting in a net margin of 1.9%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
LIF and BSX have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LIF has higher volatility (16.67%) compared to BSX (15.84%). In terms of maximum drawdown, LIF dropped -65.64% vs BSX's -89.15%.
LIF currently has the higher Sharpe Ratio (-0.43 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for LIF and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer